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Synthesis of heparan sulfate - free chains by human keratino-
cytes is upregulated during terminal differentiation. The cel-
lular location of this product class and the significance of the 
differentiation effect are unknown. Differential plasma 
membrane shearing with cationized colloidal silica was used 
to evaluate the compartmentalization of the heparan and 
chondroitin sulfate free chains and their respective proteogly-
cans in 3T3 fibroblasts and human keratinocytes. The 
method exploits the topologic segregation of plasma mem-
branes of adherent cells into ventral, dorsal, and intracellular 
domains and the selective binding of the silica to the dorsal 
membranes, w hich by shearing can be separated from ventral 
membranes adherent to the substratum. Analysis of mem-
brane preparations fro m sheared cells that had been prela-
beled with [35S]-sulfate revealed the proteoglycans to be pre-
dominantly ventral, at which location a matrix binding 
A mid the range of biologic activities that have been attributed to the proteoglycans, two general categories of function emerge from the broader perspective. In extracellular matrices, proteoglycans participate in the assembly of other matrix components. On cell sur-
faces, they are likely to be involved in the regulation of cell growth 
[1] . Whatever the precise functions within these general categories, 
the carbohydrate side chains that are attached to the core proteins of 
the proteoglycans presumably mediate some of the binding interac-
tions with ligands and other macromolecules. This biologic reactiv-
ity derives from the highly polyanionic nature and the structural 
diversity of the complex heterodimeric polymers, termed glycosa-
minoglycans (GAG), that constitute the side chains. The molecular 
heterogeneity that is inherent in the GAG has evolved the furthest 
in the case of the heparan sulfates, where such complexity likely 
represents mechanisms for the cellular regulation of the functional 
interactions of GAG with other molecules . Interest in the proteogly-
cans has recently grown due to experimental evidence suggesting a 
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function could be accommodated. Proteoglycans were also 
recovered from dorsal and intracellular membranes, suggest-
ing active trafficking between intra- and extra-cellular sites. 
In contrast, the major fraction of heparan and chondroitin 
sulfate free chains was either cytosolic or associated with 
intracellular membranes, with the remaining - 20% segre-
gated to dorsal and ventral membranes. These results suggest 
different cellular functions for the proteoglycans and glyco-
saminoglycan free chains. The partial localization of the free 
chains to peripheral membranes is compatible with our prior 
hypothesis that they arise by processing of precursor proteo-
glycans on cell surfaces. Following this origin, the free gly-
cosaminoglycan polymers could be available to bind ligands 
such as cytokines prior to transport to intracellular sites of 
action.] Invest DerrnatoI99:386 - 389, 1992 
role for heparan sulfates in regulating the mitogenic signaling of the 
fibrobl ast growth factor family of cytokines [2]. 
Although sulfated GAG are conventionally considered to func-
tion in covalent linkage to the core proteins of proteoglycans [1]. 
GAG in apparent free polymeric form have been recovered from a 
diversity of cell types under a variety of conditions (reviewed in [3]). 
From their resistance to alkaline reduction and relatively low Mr, 
these GAG free chains are distinct from the customary proteoglycan 
classes [4]. Other investigators have proposed that they represent 
intracellular lysosomal degradation products of proteoglycans based 
in part on their smaller size and inaccessibility to mild trypsinization 
of intact cells [5] . A precursor-degradative product relationship, 
however, may be an overly simplified model inadequate to accom- . 
modate all of the data. Pharmacologic inhibition oflysosomal func-
tion, for example, does not block the appearance of the free chains as 
it should if they were to arise from lysosomal processing [6]. Further-
more, a portion of the GAG free chains, in addition to most of the 
proteoglycans, has proved accessible to digestion in situ with GAG 
degrading enzymes under conditions in which cell viability is not 
materially altered [3,6]. Consequently, we have hypothesized that 
GAG free chains arise by processing from proteoglycans on cell 
surfaces, a mechanism that would provide a potential source of free 
polymer available for binding of ligands prior to transport to intra-
cellular sites of action [4]. 
One consideration bearing on the localization of cellular macro-
molecules is that cultured, adherent cells are topologically polar-
ized, such that a ventral cell membrane domain approximates the 
substratum and a dorsal domain contacts the fluid media. In addi-
tion, there is a large intracellular roo I of plasma membranes in 
equilibrium with both domains [7 . Mason and Jacobson [7] ex-
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ploited the selective binding of cationic colloidal silica to the dorsal 
surface of adherent cells to separate the compartments. With cell 
lysis, the silica-coated dorsal membranes can be separated on the 
basis of density from intracellular membrane components by centrif-
ugation, whereas the ventral domain remains adherent to the sub-
stratum. Information on the localization of cellular proteoglycans 
and GAG free chains to these domains could provide insight into 
the respective physiologic functions of the two categories of mole-
cules. In the present report, differential cell membrane separation 
achieved with the cell-shearing method was used to probe the com-
partmentalization of proteoglycans and GAG free chains in murine 
fibroblasts and human epidermal keratinocytes (HEK). 
MATERIALS AND METHODS 
Materials Chromatographic media were from Pharmacia (Pisca-
ta-way, NJ) and Bio-Rad (Richmond, CA). Tissue-culture proce-
dures utilized Corning flasks and 6-well plates (Corning, NY), 
Eagle's modified medium (Flow Laboratories, McLean, VA), and 
fetal bovine serum (Irvine Laboratories, Santa Anna, CA). GAG 
markers were bovine lung heparan sulfate [8] and chondroitin 6-
sulfate and human umbilical hyaluronan from Sigma (St. Louis, 
MO). Du Pont-New England Nuclear (Boston, MA) supplied 
Na2[3SS]04 (370 mCi/mM). A multifunctional Flavobacterial 
"heparinase," which degrades all GAG except keratan sulfate 
and lacks protease activity [9,10], was prepared as indicated [11]. 
Colloidal cationic silica was a generous gift from Mason and 
Jacobson [7]. 
Cell Lines BALB/c 3T3 clone A31 fibroblasts , purchased from 
the American Type Culture Collection (Rockville, MD), were cul-
tured in medium supplemented with 10% fetal bovine serum. HEK 
were purchased from Clonetics (San Diego, CA) and cultured with 
KGM medium according to supplied recommendations . 
Labeling and Extraction of Cellular Glycoconjugates 3T3 
fibroblasts in 75-cm2 flasks were metabolically labeled for 48 h 
under exponential growth (-75% confluence) with (3sS]-sulfate 
(90 pCi/ml) in complete growth medium. The HEK wer~ similarly 
labeled, but in KGM medium without serum. After washll1g of the 
cultures, labeled products associated with the cells or various 
membrane preparations (see below) were extracted for 30 min at 
37°C with 1% Triton X-I00 and 4 M urea in 25 mM Tris-HCl, 
pH 7.5, containing 10 mM N-ethylmaleimide, 100 mM eps~l~n­
aminocaproic acid, 10 mM EDT A, and 5 mM benzamldll1e 
HeL 
Analytical Methodology The cell and membrane preparations 
were eluted from 110 X 1 em columns of Sepharose CL-4B, with 
0 .35 m NaCI, 50 mM Tris-HCI, 0.1 % sodium dodecyl sulfate, and 
protease inhibitors as eluent. Identification of the proteoglycan and 
GAG free chain content of the fractions was obtained by the pres-
ence or absence of a K.v shift following reduction with alkaline 
borohydride (0.5 M sodium hydroxide and 0.005 M sodium boro-
hydride) for 24 h at 4 0c. Other analytical methods were as specified 
[3,12]. 
Procedure for Enzymatic Localization of Glycoconju-
gates The previously described protocol was followed for the 
digestion of intact cell layers with GAG-degrading enzymes P,4,6]. 
In brief, metabolically prelabeled cultures were treated with Flavo-
bacterial heparinase (1 mg/ml in phosphate-buffered saline) for 30 
min at 4 ° C. After washing, material remaining associated with the 
cells was extracted standardly with Triton X-I00 and protease in-
hibitors, as described above, and analyzed in parallel with that ex-
tracted from control cultures treated with buffer alone. 
Shearing Method In separate experiments, BALB/c 3T3 fibro-
blasts and HEK were cultured in 6-well plates for biochemical analy-
sis and on Falcon Cyclopore membrane inserts for histology and 
autoradiography. The cultures were prelabeled with [3SS]-sulfate for 
2 d, then one-half of them were treated with multifunctional hepa-
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Table L Shearing Studies with 3T3 Cells 
Product (10-3 X [35SJ-Sulfate dpm)' 
Condition Compartment Proteogl yean Free Chain 
No heparinase Ventral 6.9 2.2 
Dorsal 5.1 1.6 
Supernate 10.5 16.9 
Whole cellb 30.5 35.2 
Heparinase Ventral 1.1 1.2 
Dorsal 0.9 1.3 
Supernate 2.3 16.3 
Whole cellb 3.3 26.6 
• For the "no heparinase" condition, the ventral. dorsal. and supernate fractions of 
3T3 cells collectively represented 74% and 59% recovery of proteoglycans and GAG 
free chains by reference to nonsheared cultures. 
I Separate control cultures not sheared. 
rinase (1 mg/ml) and the other half with phosphate-buffered saline 
for 1 h. Cultures not to be sheared were harvested at this time for 
biochemical analysis and for histology and autoradiography. The 
remaining cultures were sheared according to Mason and Jacobson 
[7]. In brief, colloidal silica in 20 mM 4-morpholineethanesulfonic 
acid - buffered saline was added to the cultures, followed sequen-
tially by polyacrylic acid (1 mg/ml) for cross linking and hypotonic 
imidazole (2.5 mM) buffer in 50% (v/v) glycerol with 100 micro-
gram/ml heparan sulfate, as carrier, for shearing. The buffer was 
forced over the surfaces of the cultures with a pipette to facilitate 
shearing of the osmotically swollen cells. Material thus released 
from the monolayers was centrifuged to separate dorsal membranes 
adherent to the high-density silica from the supernatant fractions. 
These preparations, along with the ventral membranes remaining 
attached to the wells, were solubilized with detergent, as before, for 
biochemical analysis. The ventral membranes on the inserts were 
processed for autoradiography by standard methods. 
RESULTS 
Tables I and II contain the data from the separate experiments with 
the 3T3 fibroblasts and HEK. For the purposes of these analyses, the 
chondroitin and heparan sulfate products have been combined for 
the categories of the proteoglycans and the GAG free chains because 
previous studies have suggested minimal differences in their com-
partmentalization [3,6]. Following heparinase treatment of intact 
cells that were not sheared, 89% and 82% of 3T3 fibroblast and 
HEK proteoglycans were respectively degraded by the enzyme, by 
reference to buffer-treated, nonsheared cultures, indicating their 
accessibility on the outer leaflet of the plasma membrane. The 
values for chondroitin and heparan sulfate free chain digestion were 
24% for the 3T3 cells and 32% for the HEK products. As a reference 
to indicate the potential degree of experimental variability, 81 % and 
65% of the proteoglycans and 9% and 36% of the free chains from 
Table II. Shearing Studies with HEK Cells 
Product (10-3 X [35SJ-Sulfate dpm)' 
Condition Compartment Proteoglycan Free Chain 
No heparinase Ventral 14.0 26.0 
Dorsal 1.8 10.0 
Supernate 2.0 140 
Whole cellb 27.0 179 
Hcparinase Ventral 5.0 14.0 
Dorsal 0.2 11.0 
Supernate 1.1 87.0 
Whole cellb 4.9 122 
• For the " no heparinase" condition, the ventral, dorsal, and supernate fractions of 
HEK collectively represented 66% and 98% recovery of proteoglycans and GAG free 
chains by reference to nonsheared cultures. 
• Separate control cultures not sheared. 
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Figure 1. Autoradiographs of HEK, labeled for glycosaminoglycan con-
tent, with and without differential membrane shearing. HEK were metaboli-
cally labeled with [35S]-sulfate, treated with either buffer (A) or with multi-
functional heparinase (B), and processed by autoradiography for 48 h. The 
arrow in A indicates the Cyclopore membrane to which the HEK are adher-
ent in these vertical sections. Heparinase treatment (B) resulted in detach-
ment of the cells from the Cyclopore membrane and reduced cell-cell adhe-
sion. Separate cultures not treated with heparinase were sheared with the 
cationized colloidal silica, and autoradiographs were obtained from the 
membranes remaining attached to the substratum (C). The arrow in this 
photomicrograph indicates the ventral membrane remnants, adherent to the 
Cyclopore substratum, that are decorated with the silver grains from the 
labeled product. (Hematoxylin and eosin counterstains; original magnifica-
tions for A and Bare X400; for C, X600.) 
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the 3T3 fibroblasts and HEK, respectively, appear to be enzyme 
accessible when the buffer and heparinase treated sheared cultures 
are compared (Tables I and II). 
For purposes of illustration, the relative compartmental distribu-
tions of the proteoglycans and free chains as revealed by shearing 
were calculated on the basis of total organic isotope recovery within 
cultures (i.e., not by reference to the nonsheared cultures) (Tables I 
and II). Following shearing, 31 % of3T3, and 79% ofHEK, proteo-
glycans remained within the ventral domain with the rest appearing 
in the supernatant and dorsal preparations in a ratio of more than 
1: 1. Thus, much of the nonventral proteoglycans was seemingly 
not anchored to the dorsal membrane. For the free chain products of 
3T3 cells, 11 % was ventral , 8% was dorsal, and 82% was in the 
supernatant compartment after shearing. Values for HEK were 15% 
ventral, 6% dorsal, and 80% supernate. The 48-78% reduction in 
proteoglycans of the supernatant fraction following heparinase 
treatment (as compared with buffer-treated cultures; Tables I and II) 
could be an effect of reciprocal trafficking pathways of proteogly-
cans between intracellular and cell-surface compartments, such that 
material transported to the surface would be removed from the 
circuitry by heparinase in the culture milieu. 
The autoradiographs showed circumferential grains around con-
trol HEK (Fig lA) and 3T3 cells. A general reduction in labeling 
intensity was evident following heparinase digestion (Fig IB). Reso-
lution was not sufficient to further discriminate patterns of product 
distribution in treated or control cultures. Heparinase treatment, 
however, resulted in detachment of the cells from the substratum 
and reduced intercellular adhesion (Fig IB), effects that are in gen-
eral accord with the function of proteoglycans in cell-matrix inter-
actions [10]. With shearing, ventral cell membranes were clearly 
evident as intact sheets on the Cyclopore substrate, and decorating 
these were grains of labeled product (Fig 1 C). Thus, efficient mem-
brane domain separation was achieved with the colloidal si lica. 
DISCUSSION 
Our prior studies have emphasized the phenotypic diversity in pro-
teoglycan synthesis between cell types. The diversity includes varia-
tions in relative mass of the proteoglycans and their GAG side 
chains, in the distribution of metabolic isotopic labeling among the 
major classes of GAG, and in content of GAG free chains [3 ,4,9]. 
HEK are phenotypically distinctive, in that the chondroitin and 
heparan sulfate proteoglycans are of relatively low average Mr (50-
90 kDa), and the major fraction (-60-70%) of(3SS]-sulfate label-
ing is in apparent free chain form of mass -7 - 28 kDa [4,13] (see 
also [14]). The cellular content of heparan sulfate free chains in-
creases substantially with terminal differentiation ofHEK [13], con- . 
currently with an overall change in structure of the heparan sulfates 
[1 5]. 
Regardless of the diversity that is evident, one feature that is 
common among cells is that sulfated GAG free chains are partly 
expressed on the cell surface [3,4,6] . There have been differences, 
however, in the proportion of these products from different cell 
types that are accessible to enzymatic digestion on the external 
surface of the plasma membrane [4,13]. Compared with 3T3 fibro-
blasts, HEK in past studies have expressed pericellularly a variable 
fraction, which in part could reflect signficant experimental varia-
tion in the degree to which GAG lyases digest the HEK products in 
situ [4,13] , or alternatively an effect related to presently uncharac-
terized growth conditions. 
Because of the apparent differences between 3T3 fibroblasts and 
HEK in the surface expression of GAG free chains, as well as the 
potential interexperimental variability inherent to the past enzy-
matic digestion studies [4,13]' we probed the localization of proteo-
glycans and GAG free chains by the use of differential shearing with 
cationized colloidal si lica. The segregation of proteoheparan sul-
fates to the ventral domain of endothelial cell membranes has been 
characterized by this method [16]. Our results with the two distinct 
cell types under study were similar in certain respects, and these data 
permit some general conclusions . The majority of the HEK proteo-
glycans are in the ventral domain of the plasma membrane, in con-
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tact -wi th the culture substratum, at which location they would be 
appropriately situated to bind matrix molecules. Indeed, heparinase 
digestion of HEK resulted in reduced cell-cell and -matrix adhesion 
(Fi g lB). Less of the respective fibroblast proteoglycans, however, 
-were so distributed. For both cell types, the remaining proteogly-
cans -were partially dorsal, but a larger fraction was in the superna-
tant, representing either free cytosolic product or that associated 
with the intracellular pool of membranes. Either location could 
reflect a compartment in equilibrium with the peripheral mem-
branes. Localization for the GAG free chains was different. Al-
though the major fraction was in the supernate, - 20% of this prod-
uct -was nonetheless distributed to the combined ventral and dorsal 
dOITlains for both cell types. This result is consistent with a transient 
peripheral membrane phase. The differenc~s in localization f?r.the 
major proteoglycans and the GAG free chams could reflect dlstmct 
functions. 
The most parsimonious interpretation of all our data, which in 
addition to the present shearing studies includes differences be-
tvveen cell types and interexperimental variations in lyase accessibil-
ity [3 ,4,13]' is that the free chains are generated and transiently 
expressed on cell surfaces but are then routed to intracellular sites of 
function. The fact that - 20% of the GAG free chains were recov-
ered in the combined ventral and dorsal membrane domains after 
cell shearing is compatible with our prior hypothesis that these 
products are generated on cell surfaces. Differences in surface ex-
pression as revealed by GAG lyase accessibili ty could, according ~o 
this paradigm, reflect cell-type or growth-related differences m 
transit times between compartments. The finding of endoglycosi-
dase activity in hepatocyte plasma membranes [17] supports the 
arguITlent of cell-surface origin. The presence of heparan sulfate 
chains in hepatocyte nuclei [18] may, therefore, represent the ulti-
mate functional targeting of free chains followin g their generation 
on cell surfaces. This transport could occur in conjunction with 
bound ligands such as growth factors. 
Helen Camey, Veteratls Affairs Medical Cwter, Salt Lake City, UT, assisted with 
the autoradiographic studies. 
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